Lv11
30 积分 2023-05-21 加入
Challenges of diagnosing and managing Addison’s disease in a resource-limited setting
4小时前
求助中
TESTS OF PITUITARY-ADRENAL SUPPRESSIBILITY IN THE DIAGNOSIS OF CUSHING'S SYNDROME*
4天前
已完结
Clinical and Biochemical Data for the Diagnosis of Endogenous Hypercortisolism: The “Cushingomic” Approach
1个月前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
2个月前
已完结
Challenges and opportunities in NASH drug development
3个月前
已完结
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD
4个月前
已完结
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
4个月前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
4个月前
已完结
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease
4个月前
已完结
The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation
8个月前
已完结
皖公网安备34019202002308
